1Q'25 vs. 1Q'24 Results Sales: € 1.5 Bn (+4.7% vs. +3.4% BS(e) and -0.3% consensus); EBITDA: € 102 M (-8.1% vs. -1.8% BS(e) and -1.8% consensus); EBIT: € 53 M (-25.4% vs. -4.2% BS(e) and -8.5% consensus); Net Profit: € 10 M (-81.1% vs. -28.3% BS(e) and -28.3% consensus).
Rdos. 1T'25 vs 1T'24: Ventas: 1.551 M euros (+4,7% vs +3,4% BS(e) y -0,3% consenso); EBITDA: 102 M euros (-8,1% vs -1,8% BS(e) y -1,8% consenso); EBIT: 53 M euros (-25,4% vs -4,2% BS(e) y -8,5% consenso); BDI: 10 M euros (-81,1% vs -28,3% BS(e) y -28,3% consenso).
NACON: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Article 223-16 du Règlement Généralde l'Autorité des Marchés Financiers DateNombre total d'actions composant le capital socialDroits de vote bruts Droits de vote nets31/03/2025108 236 070161 981 247161 907 147 NACON - RCS 852 538 461Société cotée sur l’Eurolist d’Euronext Paris, compartiment BISIN : FR0013482791 ; Reuters : NACON.PA ; Bloomberg : NACON:...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.